BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Davis TM, Hunt K, McAullay D, Chubb SA, Sillars BA, Bruce DG, Davis WA. Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2012;35:2005-11. [PMID: 22815295 DOI: 10.2337/dc12-0225] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Sutherland GT, Lim J, Srikanth V, Bruce DG. Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia. JAD 2017;59:393-403. [DOI: 10.3233/jad-161194] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
2 Sainsbury E, Shi Y, Flack J, Colagiuri S. The diagnosis and management of diabetes in Australia: Does the “Rule of Halves” apply? Diabetes Research and Clinical Practice 2020;170:108524. [DOI: 10.1016/j.diabres.2020.108524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Davis TME, Chubb SAP, Curtis BH, Barraclough H, Davis WA. Temporal changes in glycaemic thresholds for treatment intensification in type 2 diabetes in an urban Australian setting: the Fremantle Diabetes Study. Intern Med J 2018;48:1215-21. [PMID: 29230931 DOI: 10.1111/imj.13710] [Reference Citation Analysis]
4 Vasant BR, Matthews V, Burgess CP, Connors CM, Bailie RS. Wide Variation in Absolute Cardiovascular Risk Assessment in Aboriginal and Torres Strait Islander People with Type 2 Diabetes. Front Public Health 2016;4:37. [PMID: 27014674 DOI: 10.3389/fpubh.2016.00037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 Drinkwater JJ, Davis TME, Hellbusch V, Turner AW, Bruce DG, Davis WA. Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II. Cardiovasc Diabetol 2020;19:43. [PMID: 32234054 DOI: 10.1186/s12933-020-01018-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Singh TP, Moxon JV, Meehan MT, Jones R, Cadet-James Y, Golledge J. Major amputation rates and outcomes for Aboriginal and Torres Strait Islander and non-Indigenous people in North Queensland Australia between 2000 and 2015. BMC Endocr Disord 2021;21:101. [PMID: 34020627 DOI: 10.1186/s12902-021-00764-z] [Reference Citation Analysis]
7 Hamilton EJ, Drinkwater JJ, Chubb SAP, Rakic V, Kamber N, Zhu K, Prince RL, Davis WA, Davis TME. A 10-Year Prospective Study of Bone Mineral Density and Bone Turnover in Males and Females With Type 1 Diabetes. J Clin Endocrinol Metab. 2018;103:3531-3539. [PMID: 30032248 DOI: 10.1210/jc.2018-00850] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
8 Delaney G, Newlyn N, Pamplona E, Hocking SL, Glastras SJ, McGrath RT, Fulcher GR. Identification of Patients With Diabetes Who Benefit Most From a Health Coaching Program in Chronic Disease Management, Sydney, Australia, 2013. Prev Chronic Dis 2017;14:E21. [PMID: 28253473 DOI: 10.5888/pcd14.160504] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
9 Baba M, Davis WA, Norman PE, Davis TM. Temporal changes in the prevalence and associates of diabetes-related lower extremity amputations in patients with type 2 diabetes: the Fremantle Diabetes Study. Cardiovasc Diabetol. 2015;14:152. [PMID: 26684912 DOI: 10.1186/s12933-015-0315-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
10 Davis WA, Zilkens RR, Starkstein SE, Davis TME, Bruce DG. Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I. Diabetologia 2017;60:89-97. [DOI: 10.1007/s00125-016-4127-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
11 Davis TME, Chubb SAP, Bruce DG, Davis WA. Metabolic memory and all-cause death in community-based patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Obes Metab 2016;18:598-606. [DOI: 10.1111/dom.12655] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Davis WA, Hellbusch V, Hunter ML, Bruce DG, Davis TME. Contemporary Cardiovascular Risk Assessment for Type 2 Diabetes Including Heart Failure as an Outcome: The Fremantle Diabetes Study Phase II. J Clin Med 2020;9:E1428. [PMID: 32403446 DOI: 10.3390/jcm9051428] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Baba M, Davis WA, Norman PE, Davis TM. Temporal changes in the prevalence and associates of foot ulceration in type 2 diabetes: the Fremantle Diabetes Study. J Diabetes Complications 2015;29:356-61. [PMID: 25670409 DOI: 10.1016/j.jdiacomp.2015.01.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
14 West M, Chuter V, Munteanu S, Hawke F. Defining the gap: a systematic review of the difference in rates of diabetes-related foot complications in Aboriginal and Torres Strait Islander Australians and non-Indigenous Australians. J Foot Ankle Res 2017;10:48. [PMID: 29151893 DOI: 10.1186/s13047-017-0230-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
15 Tan ED, Davis WA, Davis TM. Changes in characteristics and management of Asian and Anglo-Celts with type 2 diabetes over a 15-year period in an urban Australian community: The Fremantle Diabetes Study. J Diabetes. 2016;8:139-147. [PMID: 25581285 DOI: 10.1111/1753-0407.12267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 Johnson DR, McDermott RA, Clifton PM, D'Onise K, Taylor SM, Preece CL, Schmidt BA. Characteristics of Indigenous adults with poorly controlled diabetes in north Queensland: implications for services. BMC Public Health 2015;15:325. [PMID: 25884441 DOI: 10.1186/s12889-015-1660-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Power T, East L, Gao Y, Usher K, Jackson D. A mixed-methods evaluation of an urban Aboriginal diabetes lifestyle program. Aust N Z J Public Health 2021;45:143-9. [PMID: 33749953 DOI: 10.1111/1753-6405.13092] [Reference Citation Analysis]
18 Singh TP, Moxon JV, Healy GN, Cadet-James Y, Golledge J. Presentation and outcomes of indigenous Australians with peripheral artery disease. BMC Cardiovasc Disord 2018;18:94. [PMID: 29769031 DOI: 10.1186/s12872-018-0835-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
19 Davis WA, Starkstein SE, Bruce DG, Davis TM. The interactive effects of type 2 diabetes mellitus and schizophrenia on all-cause mortality: The Fremantle Diabetes Study. J Diabetes Complications 2015;29:1320-2. [PMID: 26387807 DOI: 10.1016/j.jdiacomp.2015.08.019] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Davis WA, Hamilton EJ, Bruce DG, Davis TME. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care 2019;42:102-9. [PMID: 30455327 DOI: 10.2337/dc18-1486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
21 Gauci R, Hunter M, Bruce DG, Davis WA, Davis TME. Anemia complicating type 2 diabetes: Prevalence, risk factors and prognosis. J Diabetes Complications 2017;31:1169-74. [PMID: 28433448 DOI: 10.1016/j.jdiacomp.2017.04.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
22 Davis TME, Drinkwater J, Davis WA. Proton Pump Inhibitors, Nephropathy, and Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study. The Journal of Clinical Endocrinology & Metabolism 2017;102:2985-93. [DOI: 10.1210/jc.2017-00354] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
23 Davis TME, Badshah I, Chubb SAP, Davis WA. Dose-response relationship between statin therapy and glycaemia in community-based patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Obes Metab 2016;18:1143-6. [DOI: 10.1111/dom.12710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Zhang Y, van Netten JJ, Baba M, Cheng Q, Pacella R, McPhail SM, Cramb S, Lazzarini PA. Diabetes-related foot disease in Australia: a systematic review of the prevalence and incidence of risk factors, disease and amputation in Australian populations. J Foot Ankle Res 2021;14:8. [PMID: 33468226 DOI: 10.1186/s13047-021-00447-x] [Reference Citation Analysis]
25 Mayberry LS, Lyles CR, Oldenburg B, Osborn CY, Parks M, Peek ME. mHealth Interventions for Disadvantaged and Vulnerable People with Type 2 Diabetes. Curr Diab Rep 2019;19:148. [PMID: 31768662 DOI: 10.1007/s11892-019-1280-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
26 Davis TM, Davis WA, McAullay D. Re: Essential service standards for equitable national cardiovascular care for Aboriginal and Torres Strait Islander people. Heart Lung Circ 2015;24:626. [PMID: 25666999 DOI: 10.1016/j.hlc.2015.01.003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Chung H, Ye M, Hanson C, Oladokun O, Campbell MJ, Kramer G, Lehmann OJ. Disparities in healthcare utilisation rates for Aboriginal and non-Aboriginal Albertan residents, 1997-2006: a population database study. PLoS One 2012;7:e48355. [PMID: 23152770 DOI: 10.1371/journal.pone.0048355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
28 Drinkwater JJ, Davis WA, Turner AW, McAullay D, Davis TME. Differences in retinopathy prevalence and progression between Anglo-Celt and Aboriginal Australians: the Fremantle Diabetes Study Phase II. Intern Med J 2022;52:590-8. [PMID: 33040394 DOI: 10.1111/imj.15090] [Reference Citation Analysis]
29 Davis TM, Hunt K, Bruce DG, Starkstein S, Skinner T, McAullay D, Davis WA. Prevalence of depression and its associations with cardio-metabolic control in Aboriginal and Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study Phase II. Diabetes Res Clin Pract 2015;107:384-91. [PMID: 25656760 DOI: 10.1016/j.diabres.2014.12.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
30 Barr ELM, Cunningham J, Tatipata S, Dunbar T, Kangaharan N, Guthridge S, Li SQ, Condon JR, Shaw JE, O'dea K, Maple-brown LJ. Associations of mortality and cardiovascular disease risks with diabetes and albuminuria in urban Indigenous Australians: the DRUID follow-up study. Diabet Med 2017;34:946-57. [DOI: 10.1111/dme.13360] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]